University research records
Aswan University
7 imported, source-linked research records. All imported publication dates.
All imported publication dates
Back to university profile →7 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to Aswan University are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–7 of 7 matching records. Counts update as records arrive.
Early effects of SGLT2 inhibitors in acute heart failure: an individual patient-level meta-analysis
June 16, 2026 · 2 citations · Open access
Open original record →Early effects of SGLT2 inhibitors in acute heart failure: an individual patient level meta-analysis
June 1, 2026 · 0 citations
Open original record →Targeting epicardial adipose tissue in heart failure with preserved ejection fraction: exploring the dapagliflozin connection
April 22, 2026 · 0 citations · Open access
Open original record →Lessons from a pre-specified meta-analysis of sodium-glucose cotransporter-2 (SGLT2) inhibitors in heart failure: Time for new clinical recommendations
May 8, 2023 · 5 citations · Open access
Open original record →EMMY: The continued expansion of clinical applications of SGLT2 inhibitors
February 6, 2023 · 4 citations · Open access
Open original record →EMPEROR-Preserved: SGLT2 inhibitors breakthrough in the management of heart failure with preserved ejection fraction
October 17, 2021 · 20 citations · Open access
Open original record →Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction
December 7, 2020 · 37 citations · Open access
Open original record →
